Trial intelligence / Profile preview

Mpox vaccine response after exposure

RBR-10mpz6sdPhase 4Recruiting

Sponsor
Evandro Chagas National Institute of Infectology
Start
Dec 2022
Countries
1
01

Overview

Phase 4, open-label trial in mpox (2 arms), sponsored by Evandro Chagas National Institute of Infectology. Started Dec 2022; status: recruiting.

02

Conditions

mpox

Beyond the preview

Go deeper on RBR-10mpz6sd.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-10mpz6sd.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call